kidney disease
Purespring Therapeutics Raises £80M in Series B Round to Launch Kidney Disease Gene Therapy Trial
The London-based firm said it will use the funds to advance its gene therapy pipeline, including its lead program in IgA nephropathy.
ProKidney Discontinues Late-Stage Trial to Focus on FDA Approval for Cell Therapy
A review suggested to the company that it could seek expedited approval for rilparencel in chronic kidney disease using only PROACT 1 trial results.
Vertex Starting Phase I Trial of VX-407 in Autosomal Dominant Polycystic Kidney Disease
The small molecule corrector is designed to restore PC1 protein function in a subset of patients with certain PKD1 genetic variants.
In the next decade, the MVP is looking forward to using its cache of data on 1 million veterans to better understand and address health disparities.
Renalytix Kidney Disease Test Gets FDA Clearance
The test, which assesses predictive blood-based biomarkers and electronic health record data, was first introduced in the US in late 2020 as a laboratory-developed test.